2018-2023 Global Active Pharmaceutical Ingredient (API) Market Report (Status and Outlook)

September 2018 | 117 pages | ID: 251448ACE73EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Active Pharmaceutical Ingredient (API) market for 2018-2023.

The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
Over the next five years, LPI(LP Information) projects that Active Pharmaceutical Ingredient (API) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Active Pharmaceutical Ingredient (API) market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Innovative APIS Segment
• Generic APIS Segment

Segmentation by application:

• Oncology
• Diabetes
• Cardiovascular Disease
• Cns and Neurological Disorders
• Orthopedic Disorders
• Nephrology
• Ophthalmology
• Pulmonology
• Gastrointestinal Disorders
• Endocrinology

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Teva
• Sun Pharmaceutical
• Aurobindo Pharma
• Albemarle
• Sigma-Aldrich
• Mylan
• Allergan
• ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Active Pharmaceutical Ingredient (API) market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Active Pharmaceutical Ingredient (API) market by identifying its various subsegments.
• Focuses on the key global Active Pharmaceutical Ingredient (API) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Active Pharmaceutical Ingredient (API) with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Active Pharmaceutical Ingredient (API) submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Active Pharmaceutical Ingredient (API) Market Size 2013-2023
  2.1.2 Active Pharmaceutical Ingredient (API) Market Size CAGR by Region
2.2 Active Pharmaceutical Ingredient (API) Segment by Type
  2.2.1 Innovative APIS Segment
  2.2.2 Generic APIS Segment
2.3 Active Pharmaceutical Ingredient (API) Market Size by Type
  2.3.1 Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Type (2013-2018)
  2.3.2 Global Active Pharmaceutical Ingredient (API) Market Size Growth Rate by Type (2013-2018)
2.4 Active Pharmaceutical Ingredient (API) Segment by Application
  2.4.1 Oncology
  2.4.2 Diabetes
  2.4.3 Cardiovascular Disease
  2.4.4 Cns and Neurological Disorders
  2.4.5 Orthopedic Disorders
  2.4.6 Nephrology
  2.4.7 Ophthalmology
  2.4.8 Pulmonology
  2.4.9 Gastrointestinal Disorders
  2.4.10 Endocrinology
2.5 Active Pharmaceutical Ingredient (API) Market Size by Application
  2.5.1 Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Application (2013-2018)
  2.5.2 Global Active Pharmaceutical Ingredient (API) Market Size Growth Rate by Application (2013-2018)

3 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT (API) BY PLAYERS

3.1 Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Players
  3.1.1 Global Active Pharmaceutical Ingredient (API) Market Size by Players (2016-2018)
  3.1.2 Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Players (2016-2018)
3.2 Global Active Pharmaceutical Ingredient (API) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ACTIVE PHARMACEUTICAL INGREDIENT (API) BY REGIONS

4.1 Active Pharmaceutical Ingredient (API) Market Size by Regions
4.2 Americas Active Pharmaceutical Ingredient (API) Market Size Growth
4.3 APAC Active Pharmaceutical Ingredient (API) Market Size Growth
4.4 Europe Active Pharmaceutical Ingredient (API) Market Size Growth
4.5 Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size Growth

5 AMERICAS

5.1 Americas Active Pharmaceutical Ingredient (API) Market Size by Countries
5.2 Americas Active Pharmaceutical Ingredient (API) Market Size by Type
5.3 Americas Active Pharmaceutical Ingredient (API) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Active Pharmaceutical Ingredient (API) Market Size by Countries
6.2 APAC Active Pharmaceutical Ingredient (API) Market Size by Type
6.3 APAC Active Pharmaceutical Ingredient (API) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Active Pharmaceutical Ingredient (API) by Countries
7.2 Europe Active Pharmaceutical Ingredient (API) Market Size by Type
7.3 Europe Active Pharmaceutical Ingredient (API) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Active Pharmaceutical Ingredient (API) by Countries
8.2 Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size by Type
8.3 Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET FORECAST

10.1 Global Active Pharmaceutical Ingredient (API) Market Size Forecast (2018-2023)
10.2 Global Active Pharmaceutical Ingredient (API) Forecast by Regions
  10.2.1 Global Active Pharmaceutical Ingredient (API) Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Active Pharmaceutical Ingredient (API) Forecast by Type
10.8 Global Active Pharmaceutical Ingredient (API) Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Teva
  11.1.1 Company Details
  11.1.2 Active Pharmaceutical Ingredient (API) Product Offered
  11.1.3 Teva Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Teva News
11.2 Sun Pharmaceutical
  11.2.1 Company Details
  11.2.2 Active Pharmaceutical Ingredient (API) Product Offered
  11.2.3 Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Sun Pharmaceutical News
11.3 Aurobindo Pharma
  11.3.1 Company Details
  11.3.2 Active Pharmaceutical Ingredient (API) Product Offered
  11.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Aurobindo Pharma News
11.4 Albemarle
  11.4.1 Company Details
  11.4.2 Active Pharmaceutical Ingredient (API) Product Offered
  11.4.3 Albemarle Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Albemarle News
11.5 Sigma-Aldrich
  11.5.1 Company Details
  11.5.2 Active Pharmaceutical Ingredient (API) Product Offered
  11.5.3 Sigma-Aldrich Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Sigma-Aldrich News
11.6 Mylan
  11.6.1 Company Details
  11.6.2 Active Pharmaceutical Ingredient (API) Product Offered
  11.6.3 Mylan Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Mylan News
11.7 Allergan
  11.7.1 Company Details
  11.7.2 Active Pharmaceutical Ingredient (API) Product Offered
  11.7.3 Allergan Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Allergan News

...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Active Pharmaceutical Ingredient (API)
Figure Active Pharmaceutical Ingredient (API) Report Years Considered
Figure Market Research Methodology
Figure Global Active Pharmaceutical Ingredient (API) Market Size Growth Rate 2013-2023 ($ Millions)
Table Active Pharmaceutical Ingredient (API) Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Innovative APIS Segment
Table Major Players of Generic APIS Segment
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Type (2013-2018)
Figure Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Type (2013-2018)
Figure Global Innovative APIS Segment Market Size Growth Rate
Figure Global Generic APIS Segment Market Size Growth Rate
Figure Active Pharmaceutical Ingredient (API) Consumed in Oncology
Figure Global Active Pharmaceutical Ingredient (API) Market: Oncology (2013-2018) ($ Millions)
Figure Global Oncology YoY Growth ($ Millions)
Figure Active Pharmaceutical Ingredient (API) Consumed in Diabetes
Figure Global Active Pharmaceutical Ingredient (API) Market: Diabetes (2013-2018) ($ Millions)
Figure Global Diabetes YoY Growth ($ Millions)
Figure Active Pharmaceutical Ingredient (API) Consumed in Cardiovascular Disease
Figure Global Active Pharmaceutical Ingredient (API) Market: Cardiovascular Disease (2013-2018) ($ Millions)
Figure Global Cardiovascular Disease YoY Growth ($ Millions)
Figure Active Pharmaceutical Ingredient (API) Consumed in Cns and Neurological Disorders
Figure Global Active Pharmaceutical Ingredient (API) Market: Cns and Neurological Disorders (2013-2018) ($ Millions)
Figure Global Cns and Neurological Disorders YoY Growth ($ Millions)
Figure Active Pharmaceutical Ingredient (API) Consumed in Orthopedic Disorders
Figure Global Active Pharmaceutical Ingredient (API) Market: Orthopedic Disorders (2013-2018) ($ Millions)
Figure Global Orthopedic Disorders YoY Growth ($ Millions)
Table Global Active Pharmaceutical Ingredient (API) Market Size by Application (2013-2018) ($ Millions)
Table Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Application (2013-2018)
Figure Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Application (2013-2018)
Figure Global Active Pharmaceutical Ingredient (API) Market Size in Oncology Growth Rate
Figure Global Active Pharmaceutical Ingredient (API) Market Size in Diabetes Growth Rate
Figure Global Active Pharmaceutical Ingredient (API) Market Size in Cardiovascular Disease Growth Rate
Figure Global Active Pharmaceutical Ingredient (API) Market Size in Cns and Neurological Disorders Growth Rate
Figure Global Active Pharmaceutical Ingredient (API) Market Size in Orthopedic Disorders Growth Rate
Figure Global Active Pharmaceutical Ingredient (API) Market Size in Nephrology Growth Rate
Figure Global Active Pharmaceutical Ingredient (API) Market Size in Ophthalmology Growth Rate
Figure Global Active Pharmaceutical Ingredient (API) Market Size in Pulmonology Growth Rate
Figure Global Active Pharmaceutical Ingredient (API) Market Size in Gastrointestinal Disorders Growth Rate
Figure Global Active Pharmaceutical Ingredient (API) Market Size in Endocrinology Growth Rate
Table Global Active Pharmaceutical Ingredient (API) Revenue by Players (2016-2018) ($ Millions)
Table Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Players (2016-2018)
Figure Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Players in 2017
Table Global Active Pharmaceutical Ingredient (API) Key Players Head office and Products Offered
Table Active Pharmaceutical Ingredient (API) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Active Pharmaceutical Ingredient (API) Market Size by Regions 2013-2018 ($ Millions)
Table Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Regions 2013-2018
Figure Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Regions 2013-2018
Figure Americas Active Pharmaceutical Ingredient (API) Market Size 2013-2018 ($ Millions)
Figure APAC Active Pharmaceutical Ingredient (API) Market Size 2013-2018 ($ Millions)
Figure Europe Active Pharmaceutical Ingredient (API) Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size 2013-2018 ($ Millions)
Table Americas Active Pharmaceutical Ingredient (API) Market Size by Countries (2013-2018) ($ Millions)
Table Americas Active Pharmaceutical Ingredient (API) Market Size Market Share by Countries (2013-2018)
Figure Americas Active Pharmaceutical Ingredient (API) Market Size Market Share by Countries in 2017
Table Americas Active Pharmaceutical Ingredient (API) Market Size by Type (2013-2018) ($ Millions)
Table Americas Active Pharmaceutical Ingredient (API) Market Size Market Share by Type (2013-2018)
Figure Americas Active Pharmaceutical Ingredient (API) Market Size Market Share by Type in 2017
Table Americas Active Pharmaceutical Ingredient (API) Market Size by Application (2013-2018) ($ Millions)
Table Americas Active Pharmaceutical Ingredient (API) Market Size Market Share by Application (2013-2018)
Figure Americas Active Pharmaceutical Ingredient (API) Market Size Market Share by Application in 2017
Figure United States Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Canada Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Table APAC Active Pharmaceutical Ingredient (API) Market Size by Countries (2013-2018) ($ Millions)
Table APAC Active Pharmaceutical Ingredient (API) Market Size Market Share by Countries (2013-2018)
Figure APAC Active Pharmaceutical Ingredient (API) Market Size Market Share by Countries in 2017
Table APAC Active Pharmaceutical Ingredient (API) Market Size by Type (2013-2018) ($ Millions)
Table APAC Active Pharmaceutical Ingredient (API) Market Size Market Share by Type (2013-2018)
Figure APAC Active Pharmaceutical Ingredient (API) Market Size Market Share by Type in 2017
Table APAC Active Pharmaceutical Ingredient (API) Market Size by Application (2013-2018) ($ Millions)
Table APAC Active Pharmaceutical Ingredient (API) Market Size Market Share by Application (2013-2018)
Figure APAC Active Pharmaceutical Ingredient (API) Market Size Market Share by Application in 2017
Figure China Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Japan Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Korea Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure India Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Australia Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Table Europe Active Pharmaceutical Ingredient (API) Market Size by Countries (2013-2018) ($ Millions)
Table Europe Active Pharmaceutical Ingredient (API) Market Size Market Share by Countries (2013-2018)
Figure Europe Active Pharmaceutical Ingredient (API) Market Size Market Share by Countries in 2017
Table Europe Active Pharmaceutical Ingredient (API) Market Size by Type (2013-2018) ($ Millions)
Table Europe Active Pharmaceutical Ingredient (API) Market Size Market Share by Type (2013-2018)
Figure Europe Active Pharmaceutical Ingredient (API) Market Size Market Share by Type in 2017
Table Europe Active Pharmaceutical Ingredient (API) Market Size by Application (2013-2018) ($ Millions)
Table Europe Active Pharmaceutical Ingredient (API) Market Size Market Share by Application (2013-2018)
Figure Europe Active Pharmaceutical Ingredient (API) Market Size Market Share by Application in 2017
Figure Germany Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure France Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure UK Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Italy Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Russia Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Spain Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size Market Share by Countries in 2017
Table Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size Market Share by Type in 2017
Table Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size Market Share by Application in 2017
Figure Egypt Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Israel Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Active Pharmaceutical Ingredient (API) Market Size Growth 2013-2018 ($ Millions)
Figure Global Active Pharmaceutical Ingredient (API) arket Size Forecast (2018-2023) ($ Millions)
Table Global Active Pharmaceutical Ingredient (API) Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Active Pharmaceutical Ingredient (API) Market Size Market Share Forecast by Regions
Figure Americas Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure APAC Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Europe Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure United States Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Canada Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Mexico Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Brazil Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure China Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Japan Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Korea Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure India Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Australia Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Germany Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure France Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure UK Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Italy Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Russia Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Spain Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Egypt Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure South Africa Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Israel Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure Turkey Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Figure GCC Countries Active Pharmaceutical Ingredient (API) Market Size 2018-2023 ($ Millions)
Table Global Active Pharmaceutical Ingredient (API) Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Active Pharmaceutical Ingredient (API) Market Size Market Share Forecast by Type (2018-2023)
Table Global Active Pharmaceutical Ingredient (API) Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Active Pharmaceutical Ingredient (API) Market Size Market Share Forecast by Application (2018-2023)
Table Teva Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Active Pharmaceutical Ingredient (API) Revenue and Gross Margin (2016-2018)
Figure Teva Active Pharmaceutical Ingredient (API) Market Share (2016-2018)
Table Sun Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Revenue and Gross Margin (2016-2018)
Figure Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Market Share (2016-2018)
Table Aurobindo Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Aurobindo Pharma Active Pharmaceutical Ingredient (API) Revenue and Gross Margin (2016-2018)
Figure Aurobindo Pharma Active Pharmaceutical Ingredient (API) Market Share (2016-2018)
Table Albemarle Basic Information, Head Office, Major Market Areas and Its Competitors
Table Albemarle Active Pharmaceutical Ingredient (API) Revenue and Gross Margin (2016-2018)
Figure Albemarle Active Pharmaceutical Ingredient (API) Market Share (2016-2018)
Table Sigma-Aldrich Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sigma-Aldrich Active Pharmaceutical Ingredient (API) Revenue and Gross Margin (2016-2018)
Figure Sigma-Aldrich Active Pharmaceutical Ingredient (API) Market Share (2016-2018)
Table Mylan Basic Information, Head Office, Major Market Areas and Its Competitors
Table Mylan Active Pharmaceutical Ingredient (API) Revenue and Gross Margin (2016-2018)
Figure Mylan Active Pharmaceutical Ingredient (API) Market Share (2016-2018)
Table Allergan Basic Information, Head Office, Major Market Areas and Its Competitors
Table Allergan Active Pharmaceutical Ingredient (API) Revenue and Gross Margin (2016-2018)
Figure Allergan Active Pharmaceutical Ingredient (API) Market Share (2016-2018)